Does reactogenicity after a second injection of the BNT162b2 vaccine predict spike IgG antibody levels in healthy Japanese subjects?

BACKGROUND: Adverse reactions are more common after the second injection of messenger RNA vaccines such as Pfizer/BioNTech’s BNT162b2. We hypothesized that the degree and severity of reactogenicity after the second injection reflects the magnitude of antibody production against the SARS CoV-2 virus...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Masaaki, Higa, Yukie, Esaki, Akina, Nabeshima, Yosuke, Nakazono, Akemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452080/
https://www.ncbi.nlm.nih.gov/pubmed/34543337
http://dx.doi.org/10.1371/journal.pone.0257668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452080/
https://www.ncbi.nlm.nih.gov/pubmed/34543337
http://dx.doi.org/10.1371/journal.pone.0257668

Ejemplares similares